Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
eqs_en 
0 10.04.23
EQS-News: Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
EQS-News: Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
EQS-News: Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
eqs_en 
0 10.04.23
EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
EQS-Adhoc: 2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill
eqs_en 
0 06.04.23
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
eqs_en 
0 06.04.23
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
EQS-News: Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
eqs_en 
0 05.04.23
Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
Hardman & Co Research on Tissue Regenix (TRX): Turning profitable and cash-generative
eqs_en 
0 05.04.23
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
eqs_en 
0 05.04.23
Relief Therapeutics Announces Executive Leadership Team Change
Relief Therapeutics Announces Executive Leadership Team Change
Relief Therapeutics Announces Executive Leadership Team Change
eqs_en 
0 05.04.23
EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
EQS-News: Eckert & Ziegler to Supply POINT Biopharma with Actinium-225
eqs_en 
0 04.04.23
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
eqs_en 
0 04.04.23
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
eqs_en 
0 04.04.23
EQS-News: Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
EQS-News: Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
EQS-News: Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023
eqs_en 
0 04.04.23
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders
eqs_en 
0 04.04.23
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
eqs_en 
0 03.04.23
MD Medical Group Investments Plc: MD Medical Group Annual report 2022
MD Medical Group Investments Plc: MD Medical Group Annual report 2022
MD Medical Group Investments Plc: MD Medical Group Annual report 2022
eqs_en 
0 03.04.23
MD Medical Group Investments Plc: MD Medical Group maintains strong EBITDA margin
MD Medical Group Investments Plc: MD Medical Group maintains strong EBITDA margin
MD Medical Group Investments Plc: MD Medical Group maintains strong EBITDA margin
eqs_en 
0 03.04.23
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
MD Medical Group Investments Plc: MD Medical Group announces the Annual General Meeting
eqs_en 
0 03.04.23
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board
eqs_en 
0 03.04.23
EQS-News: MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023
EQS-News: MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023
EQS-News: MediClin AG: Group sales and Group operating result above previous year − cautious outlook for 2023
eqs_en 
0 31.03.23
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech to acquire Polyplus
eqs_en 
0 31.03.23
Lonza Launches Share Buyback Program of up to CHF 2 Billion
Lonza Launches Share Buyback Program of up to CHF 2 Billion
Lonza Launches Share Buyback Program of up to CHF 2 Billion
eqs_en 
0 31.03.23
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
eqs_en 
0 30.03.23
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
Form 8.3 - The Vanguard Group, Inc.: Jounce Therapeutics Inc
eqs_en 
0 30.03.23
EQS-News: ​​​​​Eckert & Ziegler: Successful fiscal year 2022
EQS-News: ​​​​​Eckert & Ziegler: Successful fiscal year 2022
EQS-News: ​​​​​Eckert & Ziegler: Successful fiscal year 2022
eqs_en 
0 30.03.23
Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX™) with China Medical System Holdings
Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX™) with China Medical System Holdings
Cosmo announces territory expansion agreement for Lumeblue™ (Methylene Blue MMX™) with China Medical System Holdings
eqs_en 
0 30.03.23